BNP Paribas Arbitrage, SA
- SEC CIK
- 0001166588
- Latest filing
- Aug 13, 2026
PDSB holding history
PDS Biotechnology Corp in every 13F filed by BNP Paribas Arbitrage, SA, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PDSB overviewAll 13F holders of PDSBFull Q2 2026 holdings
- Shares (Q2 2026)
- 648
- Value
- $571
- % of portfolio
- <0.1%
- Quarters held
- 14
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 648 | $571 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 648 | $392 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 648 | $499 | <0.1% | −488−43.0% | Reduced | Holders |
| Q3 2025 | 1,136 | $1.15K | <0.1% | −2−0.2% | Reduced | Holders |
| Q2 2025 | 1,138 | $1.51K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 1,138 | $1.35K | <0.1% | −98−7.9% | Reduced | Holders |
| Q4 2024 | 1,236 | $2.02K | <0.1% | −41−3.2% | Reduced | Holders |
| Q3 2024 | 1,277 | $4.88K | <0.1% | −8,603−87.1% | Reduced | Holders |
| Q2 2024 | 9,880 | $28.9K | <0.1% | −4,243−30.0% | Reduced | Holders |
| Q1 2024 | 14,123 | $55.9K | <0.1% | +513+3.8% | Added | Holders |
| Q4 2023 | 13,610 | $67.6K | <0.1% | −3,975−22.6% | Reduced | Holders |
| Q3 2023 | 17,585 | $88.8K | <0.1% | +10,290+141.1% | Added | Holders |
| Q2 2023 | 7,295 | $36.7K | <0.1% | +7,295 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −26,592−100.0% | Sold out | Holders |
| Q4 2022 | 26,592 | $351.0K | <0.1% | +26,592 | New | Holders |